SEARCH

SEARCH BY CITATION

References

  • 1
    Waisbren SE, Albers S, Amato S, et al. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA 2003; 290: 256472.
  • 2
    UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. http://www.screening.nhs.uk/criteria (accessed 20 August 2012).
  • 3
    Burton H, Levene S, Alberg C, Stewart A. Tay Sachs Disease Carrier Screening in the Ashkenazi Jewish Population. Cambridge: PHG Foundation, 2009.
  • 4
    Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type 1 glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 2003; 121C: 3852.
  • 5
    Norman R, Haas M, Chaplin M, Joy P, Wilcken B. Economic evaluation of tandem mass spectrometry newborn screening in Australia. Pediatrics 2009; 123: 4517.
  • 6
    The European Organisation for Rare Diseases (EURORDIS). Rare diseases: understanding this public health priority. http://www.eurordis.org (accessed 20 August 2012).